BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 19959152)

  • 1. [Selective pituitary resistance to thyroid hormone in a patient treated with amiodarone].
    Gómez JJ; Pomar MD; Casariego AV; Rodríguez IC
    Endocrinol Nutr; 2009 Oct; 56(8):418-21. PubMed ID: 19959152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cardiovascular manifestations of thyrotoxicosis and thyroid dysfunction caused by amiodarone].
    Simkó J; Barta K; Szabó Z; Varga E; Nagy E; Lorincz I
    Orv Hetil; 2004 Nov; 145(48):2411-7. PubMed ID: 15638034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radioiodine ablation of the thyroid to allow the reintroduction of amiodarone treatment in patients with a prior history of amiodarone-induced thyrotoxicosis.
    Hermida JS; Jarry G; Tcheng E; Moullart V; Arlot S; Rey JL; Delonca J; Schvartz C
    Am J Med; 2004 Mar; 116(5):345-8. PubMed ID: 14984821
    [No Abstract]   [Full Text] [Related]  

  • 4. Amiodarone therapy effects on childhood thyroid function.
    Costigan DC; Holland FJ; Daneman D; Hesslein PS; Vogel M; Ellis G
    Pediatrics; 1986 May; 77(5):703-8. PubMed ID: 3703637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioiodine ablation of the thyroid to prevent recurrence of amiodarone-induced thyrotoxicosis in patients with resistant tachyarrhythmias.
    Hermida JS; Tcheng E; Jarry G; Moullart V; Arlot S; Rey JL; Delonca J; Schvartz C
    Europace; 2004 Mar; 6(2):169-74. PubMed ID: 15018878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amiodarone-induced thyroid dysfunction in cardiac patients from areas with iodine deficiency.
    Trifănescu R; Fica S; Barbu C; Vârtej I; Ursu H; Bunghez R; Coculescu M
    Rom J Intern Med; 2004; 42(3):595-605. PubMed ID: 16366133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amiodarone-induced thyrotoxicosis in a patient with autonomously functioning nodular goiter.
    Liang YL; Huang SM; Peng SL; Hsiao SH; Hung HC; Ou HY; Wu TJ
    Ann Pharmacother; 2009 Jan; 43(1):134-8. PubMed ID: 19109209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Approach to the patient with amiodarone-induced thyrotoxicosis.
    Bogazzi F; Bartalena L; Martino E
    J Clin Endocrinol Metab; 2010 Jun; 95(6):2529-35. PubMed ID: 20525904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determinants and outcome of amiodarone-associated thyroid dysfunction.
    Ahmed S; Van Gelder IC; Wiesfeld AC; Van Veldhuisen DJ; Links TP
    Clin Endocrinol (Oxf); 2011 Sep; 75(3):388-94. PubMed ID: 21535072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prevention of recurrent amiodarone-induced hyperthyroidism by iodine-131].
    Hermida JS; Jarry G; Tcheng E; Moullart V; Arlot S; Rey JL; Schvartz C
    Arch Mal Coeur Vaiss; 2004 Mar; 97(3):207-13. PubMed ID: 15106744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The thyroid and amiodarone (I). Changes in peripheral thyroid hormones caused by prolonged treatment with amiodarone].
    Gómez JM; Cequier A; Pérez Ayuso MJ; Sabaté X; Roca M; Marigó M
    Med Clin (Barc); 1985 Mar; 84(10):381-3. PubMed ID: 3990391
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of amiodarone on thyroid hormone economy.
    Posner J; Sobel RJ; Glick S
    Isr J Med Sci; 1984 Feb; 20(2):113-7. PubMed ID: 6423565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amiodarone induced thyroid dysfunction: pathophysiology, diagnosis and management.
    Sandhu RS; Davies PH
    Adverse Drug React Toxicol Rev; 2001 Jun; 20(2):105-16. PubMed ID: 11481999
    [No Abstract]   [Full Text] [Related]  

  • 14. [Kordaron and functional disorders of the thyroid gland].
    Zykova TA; Miroliubova OA; Kyrkalova NE; Mileĭko OS; Tkachev AV
    Klin Med (Mosk); 1991 Jun; 69(6):67-9. PubMed ID: 1774917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Amiodarone-induced thyroid gland dysfunctions].
    Gassanov N; Dietlein M; Caglayan E; Erdmann E; Er F
    Dtsch Med Wochenschr; 2010 Apr; 135(16):807-11. PubMed ID: 20391312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of thyroid metabolism on the course of INR levels in a patient with systemic anticoagulation suffering from amiodarone-induced thyrotoxicosis.
    Bucerius J; Ezziddin S; Brockmann H; Palmedo H; Biersack HJ
    Exp Clin Endocrinol Diabetes; 2007 Oct; 115(9):606-9. PubMed ID: 17943696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Amiodarone: treatment or cause of atrial fibrillation?].
    Allali G; Falconnet C
    Rev Med Suisse; 2005 Nov; 1(39):2533-5. PubMed ID: 16323735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Amiodarone and thyroid dysfunction].
    Rizzo LF; Bruno OD
    Medicina (B Aires); 2012; 72(1):63-74. PubMed ID: 22257461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effects of amiodaron on the thyroid function].
    Kucharczyk P; Michałkiewicz D; Kucharczyk A
    Pol Merkur Lekarski; 2006 Jul; 21(121):86-9. PubMed ID: 17007301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radioiodine therapy in patients with amiodarone-induced thyrotoxicosis (AIT).
    Czarnywojtek A; Czepczynski R; Ruchala M; Wasko R; Zgorzalewicz-Stachowiak M; Szczepanek E; Zamyslowska H; Bartkowiak Z; Florek E; Sowinski J
    Neuro Endocrinol Lett; 2009; 30(2):209-14. PubMed ID: 19675515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.